Bank of New York Mellon Corp
BankPosition in LXEO — Lexeo Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in LXEO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$912,079
-$743,736 QoQ
Shares Held
158,899
-4.7% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. LXEO ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in LXEO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $912,079 | 158,899 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,655,815 | 166,749 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $475,933 | 71,677 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $261,909 | 65,152 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $175,734 | 50,644 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $333,342 | 50,660 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $433,765 | 47,983 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $510,168 | 31,806 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $444,103 | 28,323 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $189,356 | 14,110 | Shares | Defined | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||